A B S T R A C T Serum amyloid protein A (SAA), the precursor of secondary amyloid protein, is elevated in chronic diseases which are associated with an increased incidence of amyloid. However, SAA is also elevated in acute bacterial and viral infections and somes forms of cancer. The murine model of caseininduced amyloidosis was studied to determine the relationship between SAA production and amyloid deposition.
INTRODUCTION
Serum amyloid protein A (SAA)l is presumed to be the precursor of the major constituent of amyloid fibrils in secondary amyloidosis (1) (2) (3) (4) (5) . It 
is present
Received for publication 23 August 1976. 'Abbreviations used in this paper: AA, secondary amyloid protein A; BSA, bovine serum albumin; SAA, serum amyloid protein A. in increased concentrations in chronic diseases such as rheumatoid arthritis, tuberculosis, and leprosy, with which an increased incidence of secondary amyloid is associated (5-7), but it has also been shown to be present in all normal human sera in small concentrations and may rise to very high levels during acute inflammatory conditions such as tonsillitis and pneumonia (8) . The fact that this serum protein is elevated in diseases which are not associated with an increased incidence of secondary amyloidosis has raised questions about the pathophysiologic mechanisms involved in its synthesis and degradation to give the fibril protein.
In the murine model in which amyloidosis is induced by chronic casein injections, the fibrils have been shown to contain a secondary amyloid protein (AA) which has amino acid analysis and N-terminal amino acid sequence which are comparable to human protein AA (9, 10) , and in the mouse there is also an SAA protein which is elevated during amyloid induction. In the present study this animal model was used to define the relationship of SAA to the development of amyloid. Serum levels of SAA were measured by radioimmunoassay in CBAIJ mice during induction of amyloid by casein injection. These levels were compared to levels of SAA protein observed in casein-treated A/J mice, a strain less susceptible to the induction of amyloid, and to SAA levels seen after injection of bovine serum albumin (BSA), an antigen which has low potential for inducing amyloid. Because of previous work in which we showed that SAA suppressed in vitro antibody response (11), SAA production was also looked for in the nude mouse treated with casein to see if SAA is a product of thymusderived (T) lymphocytes. were obtained from Mammalian Genetics, Animal Production Section, National Cancer Institute, Bethesda, Md. CBA/J mice (8-10 wk) were given 28 daily subcutaneous 0.5-ml injections of 10% casein. The animals were bled by tail vein at 0, 2, 6, 12, 16, 21, and 28 days and sera were pooled. Similarly treated mice received 21 daily injections of casein at which point the injections were stopped and the animals bled at 24, 26, and 28 days after the initiation of casein treatments. 15 A/J mice received a similar injection schedule and were bled at comparable intervals.
CBAIJ and A/J mice were also treated with 28 daily 0.5-ml injections of 5% BSA and bled at the same intervals.
Three groups of CBA/J mice received a single injection of (a) casein, (b) BSA, and (c) sterile saline. Three animals from each group were sacrificed at 3, 6, 12, 18, 24, 36, 48, and 72 h and the individual sera were stored frozen. Balb/c and Balb/Nu mice also were injected with casein and bled at 12, 24, and 48 h.
Antiserum. Amyloid fibrils, isolated from the spleens of amyloidotic CBA/J mice, were solubilized in 4 M guanidine and fractionated on Sephadex G-100 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) as previously described (8) . Protein AA was isolated as the major retarded fraction and used to produce anti-AA antiserum in New Zealand white rabbits by serial injections of AA in complete Freund's adjuvant.
Radiolabeling ofAA. Murine AA was iodinated by utilizing the methodology of Hunter (12) . AA was treated with 0.1 N NaOH for 1 h at 370C followed by neutralization with sulphuric acid. This AA protein was then iodinated with 125I (New England Nuclear, Boston, Mass.) by adding 10 ,ug of AA protein dissolved in 0.2 M barbital buffer, pH 8. was linear from the range of 2,500 ng/ml down to 25 ng/ml (Fig. 1) . Similarly, a displacement curve that utilized a pooled standard serum derived from CBAIJ mice treated with casein was linear from 10 ,l/ml down to 0.1 ,ul/ml when plotted on a log-logit graph. (Fig. 2) . Discontinuance of casein after 21 days caused a rapid decrease in the SAA level toward normal. By histologic examination spleens from representative mice at 12 days showed that one out of six had small deposits of amyloid, whereas all spleens were positive after 21 injections.
A/J mice treated with daily casein injections showed a rise in SAA to 1,700 ,uleq/ml at 2 days and a course that was not significantly different from the response in CBA/J mice throughout the 28-day experimental period. The SAA level in A/J mice also dropped precipitously after cessation of casein treatment (Fig. 2) . In contrast to the CBAIJ mice, none of the A/J mice had histologic evidence of splenic amyloid after the 28-day period. (Fig. 4) (19) 4 100 
